Pharming Group (PHAR)
9.15
+0.22
(+2.46%)
USD |
NASDAQ |
May 31, 16:00
9.105
-0.04
(-0.49%)
After-Hours: 20:00
Pharming Group Cash from Financing (Quarterly): -2.471M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -2.471M |
| December 31, 2023 | -1.02M |
| September 30, 2023 | 5.24M |
| June 30, 2023 | -2.629M |
| March 31, 2023 | -2.63M |
| December 31, 2022 | 0.278M |
| September 30, 2022 | -1.92M |
| June 30, 2022 | -0.451M |
| March 31, 2022 | -2.889M |
| December 31, 2021 | -0.215M |
| September 30, 2021 | -2.72M |
| June 30, 2021 | -22.63M |
| March 31, 2021 | -2.38M |
| December 31, 2020 | -1.095M |
| September 30, 2020 | 0.5686M |
| June 30, 2020 | 1.126M |
| March 31, 2020 | 60.09M |
| December 31, 2019 | -14.95M |
| September 30, 2019 | -6.287M |
| June 30, 2019 | -10.95M |
| March 31, 2019 | -31.29M |
| December 31, 2018 | -8.878M |
| September 30, 2018 | -10.84M |
| June 30, 2018 | -2.955M |
| March 31, 2018 | 2.128M |
| Date | Value |
|---|---|
| December 31, 2017 | -6.554M |
| September 30, 2017 | 2.680M |
| June 30, 2017 | -1.373M |
| March 31, 2017 | 1.342M |
| December 31, 2016 | 72.55M |
| September 30, 2016 | -1.142M |
| June 30, 2016 | -0.2868M |
| March 31, 2016 | -0.3094M |
| December 31, 2015 | -0.3594M |
| September 30, 2015 | 16.81M |
| June 30, 2015 | -0.0058M |
| March 31, 2015 | -0.0043M |
| December 31, 2014 | -1.641M |
| September 30, 2014 | -1.427M |
| June 30, 2014 | 19.20M |
| March 31, 2014 | 5.756M |
| December 31, 2013 | 9.991M |
| September 30, 2013 | -0.123M |
| June 30, 2013 | -0.2975M |
| March 31, 2013 | 19.55M |
| December 31, 2012 | 3.661M |
| September 30, 2012 | 2.668M |
| June 30, 2012 | -0.8462M |
| March 31, 2012 | 9.821M |
| December 31, 2011 | -1.216M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-22.63M
Minimum
Jun 2021
60.09M
Maximum
Mar 2020
-0.397M
Average
-2.15M
Median
Cash from Financing (Quarterly) Benchmarks
| uniQure NV | 0.00 |
| ProQR Therapeutics NV | -0.4551M |
| Merus NV | 30.16M |
| argenx SE | -- |
| Pharvaris NV | 0.8636M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -7.647M |
| Cash from Investing (Quarterly) | 0.664M |
| Free Cash Flow | -3.493M |
| Free Cash Flow Per Share (Quarterly) | -0.1179 |
| Free Cash Flow to Equity (Quarterly) | -4.194M |
| Free Cash Flow to Firm (Quarterly) | -7.727M |
| Free Cash Flow Yield | -0.52% |